Chongqing Zeinova Biotechnology Co., Ltd. is a comprehensive enterprise integrating technology transfer, MAH registration, trade, project service and investment.

The company‘s vision is to improve the level of basic medical and healthcare in the countries along the Belt and Road, promote the development of the pharmaceutical industry and the upgrading of production technology in these countries, and make new contributions to the development of medical and health care in the post-epidemic era.

Based on the platform of Zein Health (accounting for 20% of the ownership), it has joined hands with domestic core partners such as HEC Pharmaceutical, Pulike, SZ Weiguang, and CD BMOS to provide customers with process packages for chemical and biological drugs, meanwhile imports and exports intermediates/APIs and finished medicines. The company also provides project services, investment, clinical research, drug registration, CRO, CDMO and other comprehensive services.